» Articles » PMID: 32853985

N6-Methyladenosine Modification of the TRIM7 Positively Regulates Tumorigenesis and Chemoresistance in Osteosarcoma Through Ubiquitination of BRMS1

Overview
Journal EBioMedicine
Date 2020 Aug 28
PMID 32853985
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metastasis is the leading cause of death in patients with osteosarcoma. Some of these patients fail to respond to chemotherapy and die of metastasis within a short period. Therefore, it is important to identify novel biomarkers to improve the diagnosis and treatment of osteosarcoma. TRIM7 is a member of the tripartite motif (TRIM) family protein that is involved in various pathological conditions including cancer; however, its role in osteosarcoma remains elusive.

Methods: Cell proliferation, invasion and migration were measured by CCK-8 and Transwell. Immunoprecipitation and mass spectrometry analysis were used to identify candidate proteins associated with TRIM7. Immunoprecipitation, immunofluorescence, pull down and ubiquitination assay were performed to examine the regulation between TRIM7 and its candidate protein. m6A modification of TRIM7 was measured by RNA immunoprecipitation.

Findings: TRIM7 expression was upregulated in osteosarcoma tissues and was an independent risk factor in predicting poor prognosis. TRIM7 regulates osteosarcoma cell migration and invasion through ubiquitination of breast cancer metastasis suppressor 1 (BRMS1). Moreover, chemoresistance was readily observed in osteosarcoma cells and in patient-derived xenograft (PDX) mice with higher TRIM7 levels. Loss of TRIM7 m6A modification was observed in osteosarcoma tissues. METTL3 and YTHDF2 were the main factors involved in the aberrant m6A modification of TRIM7.

Interpretation: Overall, our findings show that TRIM7 plays a key role in regulating metastasis and chemoresistance in osteosarcoma through ubiquitination of BRMS1.

Funding: This work was financially supported by grants of NSFC (81001192, 81672658 and 81972521) and National Key Research Project of Science and Technology Ministry (2016YFC0106204).

Citing Articles

Methyltransferase-Like 3-Mediated N-Methyladenosine Modification on RNAs: A Novel Perspective for the Pathogenesis and Treatment of Bone Diseases.

Xiao D, Zhang D, Qu Y, Su X J Cell Mol Med. 2025; 29(5):e70483.

PMID: 40052548 PMC: 11886889. DOI: 10.1111/jcmm.70483.


Genomically Selected Genes Associated with a High Rate of Egg Production in Puan Panjiang Black-Bone Chickens.

Miao X, Huang Z, Liu J, Zhang L, Feng Y, Zhang Y Animals (Basel). 2025; 15(3).

PMID: 39943134 PMC: 11816201. DOI: 10.3390/ani15030363.


N-Methyladenosine modification mediated by METTL3 promotes DNA-PKcs expression to induce anlotinib resistance in osteosarcoma.

Zhang Y, Shen G, Zhang D, Meng T, Lv Z, Chen L Clin Transl Med. 2025; 15(2):e70228.

PMID: 39924638 PMC: 11807765. DOI: 10.1002/ctm2.70228.


Research progress on N6-methyladenosine RNA modification in osteosarcoma: functions, mechanisms, and potential clinical applications.

Yang Y, Ni W, Yang Y, Liao J, Yang Y, Li J Med Oncol. 2025; 42(3):55.

PMID: 39853585 DOI: 10.1007/s12032-024-02597-x.


RBM15-dependent m6A modification mediates progression of non-small cell lung cancer cells.

Wang M, Qin Y, Ai X, Liu X Mol Med. 2024; 30(1):267.

PMID: 39716068 PMC: 11665234. DOI: 10.1186/s10020-024-01018-z.


References
1.
Shi J, Liu Y, Xu X, Zhang W, Yu T, Jia J . Deubiquitinase USP47/UBP64E Regulates β-Catenin Ubiquitination and Degradation and Plays a Positive Role in Wnt Signaling. Mol Cell Biol. 2015; 35(19):3301-11. PMC: 4561727. DOI: 10.1128/MCB.00373-15. View

2.
Zhang Y, Tao R, Wu S, Xu C, Wang J, Chen J . TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. J Exp Clin Cancer Res. 2018; 37(1):116. PMC: 6001170. DOI: 10.1186/s13046-018-0780-9. View

3.
Li G, Li L, Sun Q, Wu J, Ge W, Lu G . MicroRNA-3200-5p Promotes Osteosarcoma Cell Invasion via Suppression of BRMS1. Mol Cells. 2018; 41(6):523-531. PMC: 6030248. DOI: 10.14348/molcells.2018.2200. View

4.
Bodenstine T, Vaidya K, Ismail A, Beck B, Cook L, Diers A . Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition. Cancer Res. 2010; 70(23):10002-11. PMC: 3003438. DOI: 10.1158/0008-5472.CAN-10-2606. View

5.
Lehtinen L, Ketola K, Makela R, Mpindi J, Viitala M, Kallioniemi O . High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion. Oncotarget. 2013; 4(1):48-63. PMC: 3702207. DOI: 10.18632/oncotarget.756. View